KSHV transactivator-derived small peptide traps coactivators to attenuate MYC and inhibits leukemia and lymphoma cell growth
Michiko Shimoda(University of California, San Francisco), Yoshihiro Izumiya(University of California, Davis)
Cited by 10
Related Papers
Glycans in the immune system and The Altered Glycan Theory of Autoimmunity: A critical review
|Journal of Autoimmunity|2015|461
KSHV episomes reveal dynamic chromatin loop formation with domain-specific gene regulation
|Nature Communications|2017|52
Constitutive CD40L Expression on B Cells Prematurely Terminates Germinal Center Response and Leads to Augmented Plasma Cell Production in T Cell Areas
|The Journal of Immunology|2010|41
KSHV vIL-6 enhances inflammatory responses by epigenetic reprogramming
|PLoS Pathogens|2023|10